These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3325010)

  • 41. Autoimmunity, diabetes, and chronic pancreatitis.
    Vialettes B; Lassmann V; Vague P
    Lancet; 1983 Apr; 1(8329):879. PubMed ID: 6132210
    [No Abstract]   [Full Text] [Related]  

  • 42. Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus.
    Genovese S; Bonifacio E; McNally JM; Dean BM; Wagner R; Bosi E; Gale EA; Bottazzo GF
    Diabetologia; 1992 Apr; 35(4):385-8. PubMed ID: 1516768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pre-type 1 (insulin-dependent) diabetes: common endocrinological course despite immunological and immunogenetic heterogeneity.
    Srikanta S; Ganda OP; Jackson RA; Brink SJ; Fleischnick E; Yunis E; Alper C; Soeldner JS; Eisenbarth GS
    Diabetologia; 1984 Jul; 27 Suppl():146-8. PubMed ID: 6383919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies to pancreatic islet cell antigens in diabetes seen in Southern India with particular reference to fibrocalculous pancreatic diabetes.
    Mohan V; Deepa R; Bhatia E; Singh AK; Hitman GA; Zimmet PZ; MacKay IR
    Diabet Med; 1998 Feb; 15(2):156-9. PubMed ID: 9507918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function.
    Seissler J; Hering B; Richter W; Glück M; Yassin N; Bretzel RG; Boehm BO; Federlin K; Scherbaum WA
    Diabetologia; 1992 Jun; 35(6):550-4. PubMed ID: 1612228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
    Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
    Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
    Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
    Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Islet cell antibody heterogeneity among type 1 (insulin-dependent) diabetic patients.
    Timsit J; Caillat-Zucman S; Blondel H; Chédin P; Bach JF; Boitard C
    Diabetologia; 1992 Aug; 35(8):792-5. PubMed ID: 1511808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
    Horton V; Stratton I; Bottazzo GF; Shattock M; Mackay I; Zimmet P; Manley S; Holman R; Turner R
    Diabetologia; 1999 May; 42(5):608-16. PubMed ID: 10333055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of islet cell antibodies, insulin antibodies and hyperglycaemia in 2291 schoolchildren.
    Bergua M; Solé J; Marion G; Perez MC; Recasens A; Fernàndez J; Casamitjana R; Gomis R
    Diabetologia; 1987 Sep; 30(9):724-6. PubMed ID: 3322914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Islet cell antibodies and diabetes mellitus in Pima Indians.
    Knowler WC; Bennett PH; Bottazzo GF; Doniach D
    Diabetologia; 1979 Sep; 17(3):161-4. PubMed ID: 389722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hormonal mechanisms of carbohydrate metabolism disorders in chronic pancreatitis].
    Iakhontova OI; Pomazovskaia VA
    Ter Arkh; 1991; 63(2):55-8. PubMed ID: 2048024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical aspects of the immunopathogenesis of type I diabetes mellitus].
    Scherbaum WA
    Internist (Berl); 1987 Apr; 28(4):228-35. PubMed ID: 3298122
    [No Abstract]   [Full Text] [Related]  

  • 54. [Autoimmunity in the genesis of beta-pancreatic lesions].
    Doniach D; Mirakian R; Dean B; Richardson A; Bottazzo GF
    Journ Annu Diabetol Hotel Dieu; 1984; ():151-62. PubMed ID: 6399531
    [No Abstract]   [Full Text] [Related]  

  • 55. Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics.
    Mandrup-Poulsen T; Nerup J; Stiller CR; Marner B; Bille G; Heinrichs D; Martell R; Dupre J; Keown PA; Jenner MR
    Lancet; 1985 Mar; 1(8429):599-602. PubMed ID: 2857945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
    Peig M; Gomis R; Ercilla G; Casamitjana R; Bottazzo GF; Pujol-Borrell R
    Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes.
    Harrison LC; De Aizpurua H; Loudovaris T; Campbell IL; Cebon JS; Tait BD; Colman PG
    Diabetes; 1991 Sep; 40(9):1128-33. PubMed ID: 1936620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoimmunity and diabetes associated with chronic pancreatitis.
    Scuro LA; Bovo P; Sandrini T; Angelini G; Cavallini G; Mirakian R
    Lancet; 1983 Feb; 1(8321):424. PubMed ID: 6130418
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.
    Kuglin B; Bertrams J; Linke C; Gries FA; Kolb H
    Klin Wochenschr; 1989 Jan; 67(2):66-73. PubMed ID: 2646470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.